High-Risk Non-Melanoma Skin Cancers Biological and Therapeutic Advances

被引:0
作者
Lee, Truelian [1 ,4 ]
Oka, Tomonori [2 ,3 ,5 ]
Demehri, Shadmehr [2 ,3 ,5 ]
机构
[1] Harvard Med Sch, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Ctr Canc Immunol, Ctr Canc Res, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Dept Dermatol, Boston, MA 02114 USA
[4] 25 Shattuck St, Boston, MA 02115 USA
[5] Bldg 149 13th St,Room 3-215, Charlestown, MA 02129 USA
关键词
High-risk non-melanoma skin cancer; Basal cell carcinoma; Cutaneous squamous cell carcinoma; Merkel cell carcinoma; Ultraviolet radiation; Cutaneous immunity; SQUAMOUS-CELL CARCINOMA; OPEN-LABEL; SUPPRESSOR-CELLS; PHASE-II; T-CELLS; BASAL; VISMODEGIB; MULTICENTER; EXPRESSION; INVASION;
D O I
10.1016/j.hoc.2024.05.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1071 / 1085
页数:15
相关论文
共 89 条
  • [1] Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma
    Ascierto, Paolo A.
    Schadendorf, Dirk
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (12)
  • [2] U.S. Food and Drug Administration Approval: Vismodegib for Recurrent, Locally Advanced, or Metastatic Basal Cell Carcinoma
    Axelson, Michael
    Liu, Ke
    Jiang, Xiaoping
    He, Kun
    Wang, Jian
    Zhao, Hong
    Kufrin, Dubravka
    Palmby, Todd
    Dong, Zedong
    Russell, Anne Marie
    Miksinski, Sarah
    Keegan, Patricia
    Pazdur, Richard
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (09) : 2289 - 2293
  • [3] The extracellular matrix dictates regional competence for tumour initiation
    Bansaccal, Nordin
    Vieugue, Pauline
    Sarate, Rahul
    Song, Yura
    Minguijon, Esmeralda
    Miroshnikova, Yekaterina A.
    Zeuschner, Dagmar
    Collin, Amandine
    Allard, Justine
    Engelman, Dan
    Delaunois, Anne-Lise
    Liagre, Melanie
    de Groote, Leona
    Timmerman, Evy
    Van Haver, Delphi
    Impens, Francis
    Salmon, Isabelle
    Wickstroem, Sara A.
    Sifrim, Alejandro
    Blanpain, Cedric
    [J]. NATURE, 2023, 623 (7988) : 828 - 835
  • [4] Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery
    Batra, RS
    Kelley, LC
    [J]. ARCHIVES OF DERMATOLOGY, 2002, 138 (08) : 1043 - 1051
  • [5] Myeloid Dendritic Cells from Human Cutaneous Squamous Cell Carcinoma Are Poor Stimulators of T-Cell Proliferation
    Bluth, Mark J.
    Zaba, Lisa C.
    Moussai, Dariush
    Suarez-Farinas, Mayte
    Kaporis, Helen
    Fan, Linda
    Pierson, Katherine C.
    White, Traci R.
    Pitts-Kiefer, Alexander
    Fuentes-Duculan, Judilyn
    Guttman-Yassky, Emma
    Krueger, James G.
    Lowes, Michelle A.
    Carucci, John A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (10) : 2451 - 2462
  • [6] Efficacy and tolerability of anti-PD1 antibody in combination with pulsed hedgehog inhibitor in advanced basal cell carcinoma
    Boerlin, A.
    Ramelyte, E.
    Maul, J-T.
    Nageli, M. C.
    Dummer, R.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S901 - S901
  • [7] Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease
    Burton, Kyle A.
    Ashack, Kurt A.
    Khachemoune, Amor
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2016, 17 (05) : 491 - 508
  • [8] HLA MOLECULES IN BASAL-CELL CARCINOMA OF THE SKIN
    CABRERA, T
    GARRIDO, V
    CONCHA, A
    MARTIN, J
    ESQUIVIAS, J
    OLIVA, MR
    RUIZCABELLO, F
    SERRANO, S
    GARRIDO, F
    [J]. IMMUNOBIOLOGY, 1992, 185 (05) : 440 - 452
  • [9] Cameron MC, 2021, J AM ACAD DERMATOL, V85, P535
  • [10] Cameron MC, 2019, J AM ACAD DERMATOL, V81, P310